Publications
Summary of publication
The Indo-Pacific Regulatory Strengthening Program (RSP) is an AUD$11.24 million program funded through DFAT’s Health Security Initiative (HSI) that was launched in October 2018. It is due for completion in June 2023, including a no cost extension from July 2022 to June 2023. The RSP’s goal is to strengthen capability of national regulatory authorities (NRAs) to increase the availability of quality, safe and effective medicines and medical devices. The AETAP-RSSM is a two-year AUD$8.6 million program (April 2021 to June 2023) funded through DFAT’s Regional COVID-19 Vaccine Access and Health Security Initiative (VAHSI). Its goal is to support partner countries’ efforts to deliver safe, effective and accessible COVID-19 immunisation programs based on a health and regulatory systems strengthening approach. It is noted that although the two programs have different objectives, there are significant operational and functional overlaps in terms of regulatory co-operation.
Download Publication
- Evaluation and Forward Scoping for the Therapeutic Goods Administration’s Regulatory Strengthening Program [DOCX 324 KB]
- Evaluation and Forward Scoping for the Therapeutic Goods Administration’s Regulatory Strengthening Program [PDF 718 KB]
Management Response
The TGA and DFAT welcome broad recommendations in the report, and the TGA will lead work to review technical sections of this report and will include elements that add value to the program and meet partner country needs.